These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 25392542)

  • 1. Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.
    Stachowicz A; Olszanecki R; Suski M; Wiśniewska A; Totoń-Żurańska J; Madej J; Jawień J; Białas M; Okoń K; Gajda M; Głombik K; Basta-Kaim A; Korbut R
    J Am Heart Assoc; 2014 Nov; 3(6):e001329. PubMed ID: 25392542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Analysis of Mitochondria-Enriched Fraction Isolated from the Frontal Cortex and Hippocampus of Apolipoprotein E Knockout Mice Treated with Alda-1, an Activator of Mitochondrial Aldehyde Dehydrogenase (ALDH2).
    Stachowicz A; Olszanecki R; Suski M; Głombik K; Basta-Kaim A; Adamek D; Korbut R
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological activation of aldehyde dehydrogenase 2 by Alda-1 reverses alcohol-induced hepatic steatosis and cell death in mice.
    Zhong W; Zhang W; Li Q; Xie G; Sun Q; Sun X; Tan X; Sun X; Jia W; Zhou Z
    J Hepatol; 2015 Jun; 62(6):1375-81. PubMed ID: 25543082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinyl chloride-induced interaction of nonalcoholic and toxicant-associated steatohepatitis: Protection by the ALDH2 activator Alda-1.
    Chen L; Lang AL; Poff GD; Ding WX; Beier JI
    Redox Biol; 2019 Jun; 24():101205. PubMed ID: 31026768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alda-1, an ALDH2 activator, protects against hepatic ischemia/reperfusion injury in rats via inhibition of oxidative stress.
    Zhang T; Zhao Q; Ye F; Huang CY; Chen WM; Huang WQ
    Free Radic Res; 2018 Jun; 52(6):629-638. PubMed ID: 29589772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Atherosclerotic Action of Agmatine in ApoE-Knockout Mice.
    Wiśniewska A; Olszanecki R; Totoń-Żurańska J; Kuś K; Stachowicz A; Suski M; Gębska A; Gajda M; Jawień J; Korbut R
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28777310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.
    Cansby E; Magnusson E; Nuñez-Durán E; Amrutkar M; Pedrelli M; Parini P; Hoffmann J; Ståhlman M; Howell BW; Marschall HU; Borén J; Mahlapuu M
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1723-1737. PubMed ID: 29930001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.
    Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
    Vascul Pharmacol; 2017 Sep; 96-98():19-25. PubMed ID: 28347868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase-2 activation decreases acetaminophen hepatotoxicity by prevention of mitochondrial depolarization.
    Wimborne HJ; Hu J; Takemoto K; Nguyen NT; Jaeschke H; Lemasters JJ; Zhong Z
    Toxicol Appl Pharmacol; 2020 Jun; 396():114982. PubMed ID: 32240663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
    Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X
    Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice.
    Rasmiena AA; Barlow CK; Stefanovic N; Huynh K; Tan R; Sharma A; Tull D; de Haan JB; Meikle PJ
    Atherosclerosis; 2015 Dec; 243(2):598-608. PubMed ID: 26545014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase inhibition attenuates atherosclerosis progression and liver steatosis in E
    Muhammad RS; Abu-Saleh N; Kinaneh S; Agbaria M; Sabo E; Grajeda-Iglesias C; Volkova N; Hamoud S
    Atherosclerosis; 2018 Sep; 276():155-162. PubMed ID: 30075439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alda-1 Ameliorates Liver Ischemia-Reperfusion Injury by Activating Aldehyde Dehydrogenase 2 and Enhancing Autophagy in Mice.
    Li M; Xu M; Li J; Chen L; Xu D; Tong Y; Zhang J; Wu H; Kong X; Xia Q
    J Immunol Res; 2018; 2018():9807139. PubMed ID: 30671488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Trehalose on Atherosclerosis and Hepatic Steatosis in Apolipoprotein E Knockout Mice.
    Stachowicz A; Wiśniewska A; Kuś K; Kiepura A; Gębska A; Gajda M; Białas M; Totoń-Żurańska J; Stachyra K; Suski M; Jawień J; Korbut R; Olszanecki R
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells.
    Yang MY; Wang YB; Han B; Yang B; Qiang YW; Zhang Y; Wang Z; Huang X; Liu J; Chen YD; Ren J; Cao F; Xu Y
    Acta Pharmacol Sin; 2018 Jan; 39(1):48-58. PubMed ID: 28858301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice.
    Yang X; Sun L; Li Y; Ma C; Yang J; Zhang W; Zhao B; Jia L; Duan Y; Han J; Li X; Chen Y
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):203-11. PubMed ID: 26485209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice.
    Lenglet S; Thomas A; Soehnlein O; Montecucco F; Burger F; Pelli G; Galan K; Cravatt B; Staub C; Steffens S
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):215-23. PubMed ID: 23241405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.